title: Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.
authors.forename: Sandra T A
authors.initials: ST
authors.lastname: van Bijnen
authors.forename: Roos S
authors.initials: RS
authors.lastname: van Rijn
authors.forename: Senada
authors.initials: S
authors.lastname: Koljenovic
authors.forename: Peter
authors.initials: P
authors.lastname: te Boekhorst
authors.forename: Theo
authors.initials: T
authors.lastname: de Witte
authors.forename: Petra
authors.initials: P
authors.lastname: Muus
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology* / Q000473:pathology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab